Nucleic acid aptamers - From selection in vitro to applications in vivo

Accounts of Chemical Research

Volumn 33, Issue 9, 2000, Pages 591-599

  Famulok, M ^a   Mayer, G ^a   Blind, M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DNA; LIGAND; MESSENGER RNA; NUCLEIC ACID; PROTEIN; PROTEIN INHIBITOR; REAGENT; RNA; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL; ARTICLE; BINDING SITE; BIOSENSOR; CELL FUNCTION; CHEMICAL STRUCTURE; CONFORMATION; DNA BINDING; HUMAN; MOLECULAR GENETICS; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PROTEIN TARGETING; REACTION ANALYSIS; RNA BINDING;

ANIMALS; BASE SEQUENCE; BINDING SITES; DNA; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEINS; RNA; RNA, MESSENGER;

EID: 0033797244     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar960167q     Document Type: Article

References (74)

1. Totally in vitro protein selection using mRNA-protein fusions and ribosome display
2. In vitro selection methods for screening of peptide and protein libraries
3. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase
4. In vitro selection of RNA molecules that bind specific ligands
5. Oligonucleotide libraries - Variatio delectat
6. Selecting apt RNAs for NMR
7. Structural analysis of nucleic acid aptamers
8. Aptamer structures from A to ζ
9. A biopolymer by any other name would bind as well: A comparison of the ligand-binding pockets of nucleic acids and proteins
10. Adaptive recognition by nucleic acid aptamers
11. Molecular recognition of amino acids by RNA-aptamers: An L-citrulline binding RNA motif and its evolution into an L-arginine binder
12. Isolation of RNA aptamers for biological cofactors by in vitro selection
13. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity
14. A novel RNA motif for neomycin recognition
15. In vitro selection of a viomycin-binding RNA pseudoknot
16. Oligonucleotide aptamers that recognize small molecules
17. An RNA motif that binds ATP
18. Structural basis of RNA folding and recognition in an AMP-RNA complex
19. Solution structure of an ATP-binding RNA aptamer reveals a novel fold
20. Mutant ATP-binding RNA aptamers reveal the structural basis for ligand binding
21. Structural probing and damage selection of citrullin and arginine specific RNA aptamers identify base positions required for binding
22. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy
23. Rhyme or reason: RNA-arginine interactions and the genetic code
24. Amino acids as RNA ligands: A direct-RNA-template theory for the code's origin
25. High-resolution molecular discrimination by RNA
26. In vitro selection analysis of neomycin binding RNAs with a mutagenized pool of variants of the 16S rRNA decoding region
27. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance
28. Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer
29. Molecular recognition in the FMN-RNA aptamer complex
30. Structural characterization of a flavin-specific RNA aptamer by chemical probing
31. A molecular dynamics simulation of the flavin mononucleotide-RNA aptamer complex
32. Structure, recognition and adaptive binding in RNA aptamer complexes
33. Rational design of allosteric ribozymes
34. Engineering precision RNA molecular switches
35. Allosteric regulation of a ribozyme activity through ligand-induced conformational change
36. Designing ribozymes for the inhibition of gene expression
37. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP
38. Controlling gene expression in living cells through small molecule-RNA interactions
39. RNA aptamers specifically interact with the prion protein PrP
40. Aptamers as therapeutic and diagnostic reagents: Problems and prospects
41. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies
42. Potent 2'-amino-, and 2'-fluoro-2'-deoxyri-bonucleotide RNA inhibitors of keratinocyte growth factor
43. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor
44. Cytoplasmic RNA-modulators of an inside-out signal transduction cascade
45. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo
46. In vitro and in vivo characterization of novel mRNA motifs that bind special elongation factor SelB
47. In vitro selection of RNA aptamers that bind special elongation factor SelB, a protein with multiple RNA-binding sites, reveals one major interaction domain at the carboxyl terminus
48. Natural and unnatural answers to evolutionary questions
49. Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers
50. A specific RNA hairpin loop structure binds the RNA recognition motifs of the Drosophila SR protein B52
51. RNA aptamers as effective protein antagonists in a multicellular organism
52. Genome sequence of the nematode C elegans: A platform for investigating biology. The C. elegans sequencing consortium
53. The complete genome sequence of Escherichia coli K-12
54. Life with 6000 genes
55. Genome sequences: Genome sequence of a model prokaryote
56. The DNA sequence of human chromosome 22
57. From genome to proteome: Looking at a cell's proteins
58. Of genomes and proteomes
59. Intracellular antibodies as a new class of therapeutic molecules for gene therapy
60. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases
61. Antibody scFv fragments without disulfide bonds made by molecular evolution
62. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
63. 'Mutagenesis' by peptide aptamers identifies genetic network members and pathway connections
64. A kinase-cyclin pair in the RNA polymerase II holoenzyme
65. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases
66. Regulation of integrin function by inside-out signaling mechanisms
67. Ins and outs of LFA-1
68. Automated RNA selection
69. In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor
70. Calcium-dependent oligonucleotide antagonists specific for L-selectin
71. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding
72. Inhibitory DNA ligands to platelet-derived growth factor B-chain
73. Isolation and characterization of 2'-fluoro-, 2'-amino-, and 2'-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding